GPT and COVID-19: Notably, the capacity of the De Ritis ratio to discriminate between non-severe vs. severe disease and survivor vs. non-survivor status has been shown to be superior to that of AST or ALT alone, further supporting the potential utility of the De Ritis ratio to stratify risk in patients with COVID-19 [30,31,32,33,34].